Smithfield Trust Co. cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,870 shares of the pharmacy operator’s stock after selling 600 shares during the quarter. Smithfield Trust Co.’s holdings in Walgreens Boots Alliance were worth $851,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. IBM Retirement Fund lifted its position in Walgreens Boots Alliance by 88.1% in the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after purchasing an additional 10,729 shares during the last quarter. Montecito Bank & Trust increased its stake in Walgreens Boots Alliance by 3.6% during the 2nd quarter. Montecito Bank & Trust now owns 6,661 shares of the pharmacy operator’s stock valued at $522,000 after buying an additional 230 shares during the period. Wellington Management Group LLP increased its stake in Walgreens Boots Alliance by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the period. Putnam FL Investment Management Co. increased its stake in Walgreens Boots Alliance by 1,037.3% during the 1st quarter. Putnam FL Investment Management Co. now owns 74,860 shares of the pharmacy operator’s stock valued at $6,217,000 after buying an additional 68,278 shares during the period. Finally, Sumitomo Mitsui Asset Management Company LTD increased its stake in Walgreens Boots Alliance by 9.3% during the 1st quarter. Sumitomo Mitsui Asset Management Company LTD now owns 75,821 shares of the pharmacy operator’s stock valued at $6,296,000 after buying an additional 6,462 shares during the period. Hedge funds and other institutional investors own 60.16% of the company’s stock.

In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 13.50% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/smithfield-trust-co-sells-600-shares-of-walgreens-boots-alliance-inc-wba/1600017.html.

Walgreens Boots Alliance, Inc. (WBA) opened at 77.22 on Friday. The stock has a market capitalization of $82.63 billion, a P/E ratio of 19.50 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69. The stock has a 50 day moving average of $81.36 and a 200 day moving average of $81.86.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. Walgreens Boots Alliance’s revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.18 EPS. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were paid a $0.40 dividend. The ex-dividend date was Wednesday, August 16th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.07%. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

Walgreens Boots Alliance announced that its Board of Directors has approved a share repurchase plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its stock is undervalued.

Several equities analysts have commented on the stock. Royal Bank Of Canada assumed coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 target price on the stock. Needham & Company LLC reissued a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, June 14th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $92.06.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.